4//SEC Filing
Jones Michael L 4
Accession 0001127602-22-026834
CIK 0000882796other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 6:36 PM ET
Size
8.2 KB
Accession
0001127602-22-026834
Insider Transaction Report
Form 4
Jones Michael L
Exec. Director, Finance - PAO
Transactions
- Exercise/Conversion
Common Stock
2022-12-01$1.42/sh+8,600$12,212→ 19,798 total - Sale
Common Stock
2022-12-01$13.01/sh−8,600$111,886→ 11,198 total - Exercise/Conversion
Emp. Stock Option (Right to Buy)
2022-12-01−8,600→ 0 totalExercise: $1.42From: 2014-01-01Exp: 2023-01-01→ Common Stock (8,600 underlying)
Footnotes (1)
- [F1]The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $13.01 to $13.03. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001800060
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 6:36 PM ET
- Size
- 8.2 KB